Search results for: HTA
Filter search results
Time Trends in NICE HTA Decision Making: Setting the Record Straight
21 May 2012
…directly control. Each represents a different, but legitimate and useful way, of measuring the time taken in HTA. For further comment on time trends in NICE HTA decision making, see…
Spotlight on OHE: NICE, Biosimilars, HTA
17 June 2014
…UK HTA agencies, the MHRA and academia were involved in debating which HTA methods are most appropriate for biosimilars in specific situations. The Role of HTA for Biosimilars Mestre-Ferrandiz 2014…
OHE at HTAi Oslo: A New Drug Development Paradigm, and the Effect of NICE Decisions Abroad
19 June 2015
This post summarises OHE’s activities at this year HTAi meeting in Oslo, June 2015. Topics include the effect of NICE decisions abroad and a new drug development paradigm. HTAi’s 12th…
OHE at the 2019 Health Technology Assessment International (HTAi) Annual Meeting
7 June 2019
…Assessment International (HTAi) 2019 annual meeting in Cologne, 15-19 June. The 2019 HTAi annual meeting will take place from 15th to 19th June in Cologne, Germany, with the theme HTA…
What is the Role of HTA for Biosimilars?
1 April 2014
This Briefing summarises the results of a roundtable convened by OHE to discuss using HTA to assess biosimilars – including which methods are most appropriate in specific situations. Participating were…
OHE at HTAi 2018
29 May 2018
…International (HTAi) 2018 conference in Vancouver, 1-5 June. Later this week, Adrian Towse, Koonal Shah, Grace Hampson, and Chris Sampson will be travelling to Vancouver, Canada, to participate in HTAi…
Presentations from ISPOR and HTAi 2018
12 July 2018
OHE staff recently attended ISPOR and HTAi international conferences. In this blog post, we share a selection of our presentations. OHE staff recently attended ISPOR and HTAi international conferences. In…
OHE Lunchtime Seminar: ‘Age, Utilities, and Self-Reported Health: Issues for HTA’
17 May 2016, 11:00pm
…health: issues for HTA’. Occasionally, in health technology assessments (HTA), the situation arises that the central estimate of patients’ HRQoL available from clinical trials exceeds that of the general population…
The Future of NICE in a Changing HTA Landscape
27 March 2024, 2:00pm
…our moderator, Chris Sampson (Senior Principal Economist, OHE). These interviews captured the most pressing issues and advancements in HTA, exploring what the future of HTA will look like over the coming years. The…